The influence of non-radioactive iodine (127I) on the outcome of radioiodine (131I) therapy in patients with Graves' disease and toxic nodular goitre

The aim of the study was to achieve an effective target dose in the thyroid by increasing the effective half-life (Teff) of (131)I by use of iodide ((127)I) two days after (131)I therapy in patients with hyperthyroidism with low Teff. The study was carried out in two groups. Group A - 41 patients, a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nuclear medicine review. Central & Eastern Europe 2011-01, Vol.14 (1), p.9-15
Hauptverfasser:	Rogowski, Franciszek, Abdelrazek, Saeid, Szumowski, Piotr, Zonenberg, Anna, Parfienczyk, Adam, Sawicka, Agnieszka
Format:	Artikel
Sprache:	eng
Schlagworte:	Female Goiter, Nodular - blood Goiter, Nodular - metabolism Goiter, Nodular - radiotherapy Graves Disease - blood Graves Disease - metabolism Graves Disease - radiotherapy Half-Life Humans Hyperthyroidism Iodine - pharmacology Iodine Radioisotopes - metabolism Iodine Radioisotopes - therapeutic use Male Middle Aged Radiotherapy Dosage Thyroid gland Thyroid Gland - drug effects Thyroid Gland - metabolism Thyroid Gland - radiation effects Time Factors Treatment Outcome Triiodothyronine - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!